 Editas Medicine, Inc. NASDAQ:EDIT Q1 2022 Results Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants Ron Moldaver - Investor Relations Jim Mullen - Chief Executive Officer Mark Shearman - Chief Scientific Officer Michelle Robertson - Chief Financial Officer Charlene Stern - General Counsel. Conference Call Participants Joon Lee - Truist Joel Beatty - Baird Dae Gon Ha - Stifel Steven Seedhouse - Raymond James Rick Bienkowski - SVB Securities Luca Issi - RBC Capital Liisa Bayko - Evercore ISI Operator Good morning and welcome to the Editas Medicine First Quarter 2022 Conference Call. 